1214336-90-9

Basic information

• Product Name: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine
• Synonyms: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine
• CAS NO: 1214336-90-9
• Molecular Formula: C₆H₂BrF₃N₂O₂
• Molecular Weight: 270.9914896
• Mol File: 1214336-90-9.mol

Chemical Properties

• Boiling Point: 243℃
• Flash Point: 101℃
• Appearance: /
• Density: 1.879
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -5.67±0.20(Predicted)
• CAS DataBase Reference: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine(1214336-90-9)
• EPA Substance Registry System: 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine(1214336-90-9)

Safety Data

• Hazardous Substances Data: 1214336-90-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-3-nitro-5-(trifluoromethyl)pyridine is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine serves as an intermediate in the production of agrochemicals, aiding in the creation of compounds that can be used in pest control and crop protection.
Used in Biological Research:
2-Bromo-3-nitro-5-(trifluoromethyl)pyridine is utilized in biological research for studying its potential anti-inflammatory and anti-cancer properties. Its unique chemical features make it a candidate for further exploration in medicinal chemistry and drug discovery.
Used as a Building Block in Organic Synthesis:
Owing to its reactive functional groups, 2-Bromo-3-nitro-5-(trifluoromethyl)pyridine is employed as a versatile building block in organic synthesis. It allows for the construction of diverse chemical compounds, expanding the scope of synthetic chemistry and potentially leading to new materials and pharmaceuticals.

Upstream product

• 33252-64-1 3-nitro-5-trifluoromethylpyridin-2-ol 

Downstream Products

• 866775-16-8 3-nitro-5-trifluoromethyl-pyridine-2-carbonitrile 
• 1427400-25-6 3-amino-6-(4-fluorophenyl)-N-(1H-pyrazol-3-yl)-5-(trifluoromethyl)picolinamide 
• 1427400-35-8 methyl 3-amino-6-(4-fluorophenyl)-5-(trifluoromethyl)picolinate 
• 1427262-80-3 (R)-2-(5-(amino(phenyl)methyl)-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-83-6 (R)-benzyl (5-(3-amino-6-bromo-5-(trifluoromethyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)(phenyl)methylcarbamate 
• 1427262-81-4 (R)-benzyl 2-(2-(3-amino-6-bromo-5-(trifluoromethyl)picolinoyl)hydrazinyl)-2-oxo-1-phenylethylcarbamate 
• 1427262-60-9 2-(5-benzyl-1,3,4-oxadiazol-2-yl)-6-bromo-5-(trifluoromethyl)pyridin-3-amine 
• 1427262-61-0 3-amino-6-bromo-N'-(2-phenylacetyl)-5-(trifluoromethyl)picolinohydrazide 
• 1334546-80-3 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl)amide 
• 1211515-30-8 3-amino-5-(trifluoromethyl)picolinonitrile 
• 1334547-23-7 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid methyl ester 
• 1334547-21-5 3-amino-6-(4-fluorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 
• 1214370-77-0 3-amino-5-trifluoromethylpyridine-2-carboxylic acid 
• 1334546-83-6 3-amino-6-(2,4-dichlorophenyl)-5-trifluoromethylpyridine-2-carboxylic acid 

Relevant articles and documents

Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

Pyridine derivative PIM kinase inhibitor and preparation method therefor and application thereof in pharmacy

The present invention provides a PIM kinase inhibitor and a preparation method therefor and an application thereof. The PIM kinase inhibitor is a compound with the structural formula shown in the formula I (the formula is shown in description). The present invention further provides a stereoisomer, a tautomer and pharmaceutical salt of the compound shown in the formula I. According to the present invention, the compound has an obvious inhibition effect on kinase activity. The PIM kinase inhibitor can be used for preparing drugs for curing or preventing cancer, autoimmune diseases, allergic reaction diseases or organ transplant rejection resistance and the like, and the PIM kinase inhibitor has relatively large value in clinical application.

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS

The present invention provides pyridin-oxadiazole/thiadiazole derivatives of Formula I wherein A is N or CR 4a; and (ii) or (iii) which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

PYRIDINE AMIDE DERIVATIVES

The present invention provides pyridine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory

Pyridine amide derivatives

The present invention provides pyridine amide derivatives which re? store or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, resp

PYRIDINE/PYRAZINE AMIDE DERIVATIVES

The present invention provides pyridine/pyrazine amide derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthm

N-SUBSTITUTED HETEROCYCLYL CARBOXAMIDES

A compound of Formula I and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, Ra, A, B, D and E are all as defined herein. The compounds modulate the activity of CFTR and are useful in

Pyridine and Pyrazine derivative for the Treatment of CF

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.